Form 8-K ENANTA PHARMACEUTICALS For: Aug 11
Tweet
Share
E-mail
http://archive.fast-edgar.com/20140811/AI2BFG2FZ22R9ZZ2222R2ZXQVQPSZZ22X262
Filed on: August 11, 2014
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Enanta advances RSV drug zelicapavir into late-stage trials
- Inomin Mines Selected as One of Canada's Leading Emerging Critical Minerals Companies for Largest-Ever Trade Mission to Japan
- Syntholene Completes Construction of Iceland Demonstration Facility Six Months Ahead of Schedule, Commences Operations
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
